Current Concepts in Imaging Diabetic Pedal Osteomyelitis

Radiologic Clinics of North America

Volumn 46, Issue 6, 2008, Pages 1105-1124

  Donovan, Andrea ^a   Schweitzer, Mark E ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Diabetes; Foot; Imaging; Neuropathic arthritis; Osteomyelitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MEDRONATE TECHNETIUM TC 99M; TECHNETIUM 99M;

ABSCESS; ARTHROPATHY; BONE SCINTISCANNING; CALLUS; CELLULITIS; DIABETES MELLITUS; DIABETIC PEDAL OSTEOMYELITIS; DIAGNOSTIC ACCURACY; DRUG UPTAKE; ECHOGRAPHY; EDEMA; GANGRENE; HUMAN; INFECTION; ISCHEMIA; LIMB AMPUTATION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SOFT TISSUE INFECTION; TISSUE PERFUSION;

DIABETES COMPLICATIONS; FOOT; FOOT DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS;

EID: 56749098079     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2008.08.004     Document Type: Review

References (115)

1. Reiber G.E., Lipsky B.A., and Gibbons G.W. The burden of diabetic foot ulcers. Am J Surg 176 2A Suppl (1998) 5S-10S
2. Gordois A., Scuffham P., Shearer A., et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 26 6 (2003) 1790-1795
3. Singh N., Armstrong D.G., and Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 293 2 (2005) 217-228
4. Lavery L.A., Armstrong D.G., Wunderlich R.P., et al. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 26 5 (2003) 1435-1438
5. Armstrong D.G., and Lipsky B.A. Advances in the treatment of diabetic foot infections. Diabetes Technol Ther 6 2 (2004) 167-177
6. Armstrong D.G., and Lipsky B.A. Diabetic foot infections: stepwise medical and surgical management. Int Wound J 1 2 (2004) 123-132
7. Lavery L.A., Armstrong D.G., Wunderlich R.P., et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care 29 6 (2006) 1288-1293
8. Reiber G.E. The epidemiology of diabetic foot problems. Diabet Med 13 Suppl 1 (1996) S6-S11
9. Lipsky B.A. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 25 6 (1997) 1318-1326
10. Lipsky B.A., Berendt A.R., Deery H.G., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39 7 (2004) 885-910
11. Morrison W.B., Schweitzer M.E., Wapner K.L., et al. Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging. Radiology 196 2 (1995) 557-564
12. Trautner C., Haastert B., Giani G., et al. Incidence of lower limb amputations and diabetes. Diabetes Care 19 9 (1996) 1006-1009
13. Jeffcoate W.J., and Harding K.G. Diabetic foot ulcers. Lancet 361 9368 (2003) 1545-1551
14. Berendt A.R., Peters E.J., Bakker K., et al. Specific guidelines for treatment of diabetic foot osteomyelitis. Diabetes Metab Res Rev 24 Suppl 1 (2008) S190-S191
15. Bamberger D.M., Daus G.P., and Gerding D.N. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 83 4 (1987) 653-660
16. Senneville E., Lombart A., Beltrand E., et al. Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 31 4 (2008) 637-642
17. Yasuhara H., Hattori T., and Shigeta O. Significance of phlebosclerosis in non-healing Ischaemic foot ulcers of end-stage renal disease. Eur J Vasc Endovasc Surg 36 3 (2008) 346-352
18. Faglia E., Mantero M., Caminiti M., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 252 3 (2002) 225-232
19. Durham J.R., Lukens M.L., Campanini D.S., et al. Impact of magnetic resonance imaging on the management of diabetic foot infections. Am J Surg 162 2 (1991) 150-153 [discussion: 153-4]
20. Horowitz J.D., Durham J.R., Nease D.B., et al. Prospective evaluation of magnetic resonance imaging in the management of acute diabetic foot infections. Ann Vasc Surg 7 1 (1993) 44-50
21. Lipsky B.A., Pecoraro R.E., and Wheat L.J. The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am 4 3 (1990) 409-432
22. Stadelmann W.K., Digenis A.G., and Tobin G.R. Impediments to wound healing. Am J Surg 176 2A Suppl (1998) 39S-47S
23. Rathur H.M., and Boulton A.J. The neuropathic diabetic foot. Nat Clin Pract Endocrinol Metab 3 1 (2007) 14-25
24. Ierardi R.P., and Shuman C.R. Control of vascular disease in patients with diabetes mellitus. Surg Clin North Am 78 3 (1998) 385-392
25. Andreisek G., Pfammatter T., Goepfert K., et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology 242 2 (2007) 610-620
26. Lapeyre M., Kobeiter H., Desgranges P., et al. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 185 6 (2005) 1641-1650
27. Kreitner K.F., and Schmitt R. MultiHance-enhanced MR angiography of the peripheral run-off vessels in patients with diabetes. Eur Radiol 17 Suppl 6 (2007) F63-F68
28. Faglia E., Dalla Paola L., Clerici G., et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 29 6 (2005) 620-627
29. Edmonds M.E., Roberts V.C., and Watkins P.J. Blood flow in the diabetic neuropathic foot. Diabetologia 22 1 (1982) 9-15
30. Younger D.S., and Bronfin L. Overview of diabetic neuropathy. Semin Neurol 16 2 (1996) 107-113
31. Reiber G.E., Vileikyte L., Boyko E.J., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22 1 (1999) 157-162
32. Shone A., Burnside J., Chipchase S., et al. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 29 4 (2006) 945
33. Lavery L.A., Armstrong D.G., Peters E.J., et al. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic?. Diabetes Care 30 2 (2007) 270-274
34. Bridges Jr. R.M., and Deitch E.A. Diabetic foot infections. Pathophysiology and treatment. Surg Clin North Am 74 3 (1994) 537-555
35. Wheat L.J., Allen S.D., Henry M., et al. Diabetic foot infections. Bacteriologic analysis. Arch Intern Med 146 10 (1986) 1935-1940
36. Schweitzer M.E., Daffner R.H., Weissman B.N., et al. ACR appropriateness criteria on suspected osteomyelitis in patients with diabetes mellitus. J Am Coll Radiol 5 8 (2008) 881-886
37. Caputo G.M., Cavanagh P.R., Ulbrecht J.S., et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med 331 13 (1994) 854-860
38. Levine S.E., Neagle C.E., Esterhai J.L., et al. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer. Foot Ankle Int 15 3 (1994) 151-156
39. Shults D.W., Hunter G.C., McIntyre K.E., et al. Value of radiographs and bone scans in determining the need for therapy in diabetic patients with foot ulcers. Am J Surg 158 6 (1989) 525-529 [discussion: 529-30]
40. Enderle M.D., Coerper S., Schweizer H.P., et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound. Diabetes Care 22 2 (1999) 294-299
41. Capriotti G., Chianelli M., and Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun 27 10 (2006) 757-764
42. Kumar R., Basu S., Torigian D., et al. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev 21 1 (2008) 209-224
43. Jay P.R., Michelson J.D., Mizel M.S., et al. Efficacy of three-phase bone scans in evaluating diabetic foot ulcers. Foot Ankle Int 20 6 (1999) 347-355
44. Sella E.J., and Grosser D.M. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg 20 4 (2003) 729-740
45. Larcos G., Brown M.L., and Sutton R.T. Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy. AJR Am J Roentgenol 157 3 (1991) 527-531
46. Termaat M.F., Raijmakers P.G., Scholten H.J., et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 87 11 (2005) 2464-2471
47. Schauwecker D.S. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol 158 1 (1992) 9-18
48. Poirier J.Y., Garin E., Derrien C., et al. Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab 28 6 Pt 1 (2002) 485-490
49. Rubello D., Casara D., Maran A., et al. Role of anti-granulocyte Fab' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results. Nucl Med Commun 25 1 (2004) 39-47
50. Delcourt A., Huglo D., Prangere T., et al. Comparison between leukoscan (sulesomab) and gallium-67 for the diagnosis of osteomyelitis in the diabetic foot. Diabetes Metab 31 2 (2005) 125-133
51. Sugawara Y., Braun D.K., Kison P.V., et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 25 9 (1998) 1238-1243
52. Bleeker-Rovers C.P., de Kleijn E.M., Corstens F.H., et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 31 1 (2004) 29-37
53. Giurato L., and Uccioli L. The diabetic foot: Charcot joint and osteomyelitis. Nucl Med Commun 27 9 (2006) 745-749
54. Keidar Z., Militianu D., Melamed E., et al. The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med 46 3 (2005) 444-449
55. Hopfner S., Krolak C., Kessler S., et al. Preoperative imaging of charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int 25 12 (2004) 890-895
56. Basu S., Chryssikos T., Houseni M., et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?. Nucl Med Commun 28 6 (2007) 465-472
57. Gold R.H., Hawkins R.A., and Katz R.D. Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol 157 2 (1991) 365-370
58. Chandnani V.P., Beltran J., Morris C.S., et al. Acute experimental osteomyelitis and abscesses: detection with MR imaging versus CT. Radiology 174 1 (1990) 233-236
59. Riebel T.W., Nasir R., and Nazarenko O. The value of sonography in the detection of osteomyelitis. Pediatr Radiol 26 4 (1996) 291-297
60. Kapoor A., Page S., Lavalley M., et al. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 167 2 (2007) 125-132
61. Fry D.E., Marek J.M., and Langsfeld M. Infection in the ischemic lower extremity. Surg Clin North Am 78 3 (1998) 465-479
62. Sumpio B.E. Foot ulcers. N Engl J Med 343 11 (2000) 787-793
63. Deo A., Fogel M., and Cowper S.E. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2 2 (2007) 264-267
64. Broome D.R., Girguis M.S., Baron P.W., et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188 2 (2007) 586-592
65. Sadowski E.A., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243 1 (2007) 148-157
66. US Food and Drug Administration. Gadolinium-based contrast agents for magnetic resonance imaging (marketed as Magnevist M, Omniscan, OptiMARK, ProHance). Available at:. http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200705HCP.pdf Accessed July 30, 2008
67. Kanal E., Barkovich A.J., Bell C., et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 188 6 (2007) 1447-1474
68. Birke J.A., Franks B.D., and Foto J.G. First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle Int 16 5 (1995) 277-284
69. Birke J.A., Patout Jr. C.A., and Foto J.G. Factors associated with ulceration and amputation in the neuropathic foot. J Orthop Sports Phys Ther 30 2 (2000) 91-97
70. Ledermann H.P., Morrison W.B., and Schweitzer M.E. MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis. Radiology 223 3 (2002) 747-755
71. Mueller M.J., Minor S.D., Diamond J.E., et al. Relationship of foot deformity to ulcer location in patients with diabetes mellitus. Phys Ther 70 6 (1990) 356-362
72. Boulton A.J. The pathogenesis of diabetic foot problems: an overview. Diabet Med 13 Suppl 1 (1996) S12-S16
73. Pitei D.L., Foster A., and Edmonds M. The effect of regular callus removal on foot pressures. J Foot Ankle Surg 38 4 (1999) 251-255 [discussion: 306]
74. Levin M.E. Foot lesions in patients with diabetes mellitus. Endocrinol Metab Clin North Am 25 2 (1996) 447-462
75. Morrison W.B., Schweitzer M.E., Bock G.W., et al. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging. Radiology 189 1 (1993) 251-257
76. Morrison W.B., Schweitzer M.E., Batte W.G., et al. Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs. Radiology 207 3 (1998) 625-632
77. Ledermann H.P., Morrison W.B., and Schweitzer M.E. Pedal abscesses in patients suspected of having pedal osteomyelitis: analysis with MR imaging. Radiology 224 3 (2002) 649-655
78. Schweitzer M.E., and Morrison W.B. MR imaging of the diabetic foot. Radiol Clin North Am 42 1 (2004) 61-71 vi
79. Tomas M.B., Patel M., Marwin S.E., et al. The diabetic foot. Br J Radiol 73 868 (2000) 443-450
80. Moore T.E., Yuh W.T., Kathol M.H., et al. Abnormalities of the foot in patients with diabetes mellitus: findings on MR imaging. AJR Am J Roentgenol 157 4 (1991) 813-816
81. Chatha D.S., Cunningham P.M., and Schweitzer M.E. MR imaging of the diabetic foot: diagnostic challenges. Radiol Clin North Am 43 4 (2005) 747-759 ix
82. Ledermann H.P., Schweitzer M.E., and Morrison W.B. Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess. AJR Am J Roentgenol 178 1 (2002) 215-222
83. Weber M.A., Krix M., and Delorme S. Quantitative evaluation of muscle perfusion with CEUS and with MR. Eur Radiol 17 10 (2007) 2663-2674
84. Panchbhavi V.K., and Hecox S.E. All that is gas is not gas gangrene: mechanical spread of gas in the soft tissues. A case report. J Bone Joint Surg Am 88 6 (2006) 1345-1348
85. Brower A.C. Septic arthritis. Radiol Clin North Am 34 2 (1996) 293-309 x
86. Karchevsky M., Schweitzer M.E., Morrison W.B., et al. MRI findings of septic arthritis and associated osteomyelitis in adults. AJR Am J Roentgenol 182 1 (2004) 119-122
87. Graif M., Schweitzer M.E., Deely D., et al. The septic versus nonseptic inflamed joint: MRI characteristics. Skeletal Radiol 28 11 (1999) 616-620
88. Goodwin D.W., Salonen D.C., Yu J.S., et al. Plantar compartments of the foot: MR appearance in cadavers and diabetic patients. Radiology 196 3 (1995) 623-630
89. Ledermann H.P., Morrison W.B., Schweitzer M.E., et al. Tendon involvement in pedal infection: MR analysis of frequency, distribution, and spread of infection. AJR Am J Roentgenol 179 4 (2002) 939-947
90. Boutin R.D., Brossmann J., Sartoris D.J., et al. Update on imaging of orthopedic infections. Orthop Clin North Am 29 1 (1998) 41-66
91. Sella E.J., and Barrette C. Staging of charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 38 1 (1999) 34-40
92. Morrison W.B., and Ledermann H.P. Work-up of the diabetic foot. Radiol Clin North Am 40 5 (2002) 1171-1192
93. Marcus C.D., Ladam-Marcus V.J., Leone J., et al. MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics 16 6 (1996) 1337-1348
94. Yuh W.T., Corson J.D., Baraniewski H.M., et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging. AJR Am J Roentgenol 152 4 (1989) 795-800
95. Clouse M.E., Gramm H.F., Legg M., et al. Diabetic osteoarthropathy. Clinical and roentgenographic observations in 90 cases. Am J Roentgenol Radium Ther Nucl Med 121 1 (1974) 22-34
96. Brower A.C., and Allman R.M. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 139 2 (1981) 349-354
97. Ahmadi M.E., Morrison W.B., Carrino J.A., et al. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology 238 2 (2006) 622-631
98. Tan P.L., and Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol 80 959 (2007) 939-948
99. Gold G.E., Suh B., Sawyer-Glover A., et al. Musculoskeletal MRI at 3.0 T: initial clinical experience. AJR Am J Roentgenol 183 5 (2004) 1479-1486
100. Ruhl K.M., Katoh M., Langer S., et al. Time-resolved 3D MR angiography of the foot at 3 T in patients with peripheral arterial disease. AJR Am J Roentgenol 190 6 (2008) W360-W364
101. Chomel S., Douek P., Moulin P., et al. Contrast-enhanced MR angiography of the foot: anatomy and clinical application in patients with diabetes. AJR Am J Roentgenol 182 6 (2004) 1435-1442
102. Regatte R.R., and Schweitzer M.E. Ultra-high-field MRI of the musculoskeletal system at 7.0T. J Magn Reson Imaging 25 2 (2007) 262-269
103. Shapiro E.M., Borthakur A., Dandora R., et al. Sodium visibility and quantitation in intact bovine articular cartilage using high field (23)Na MRI and MRS. J Magn Reson 142 1 (2000) 24-31
104. Borthakur A., Shapiro E.M., Beers J., et al. Sensitivity of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton MRI. Osteoarthritis Cartilage 8 4 (2000) 288-293
105. Borthakur A., Mellon E., Niyogi S., et al. Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage. NMR Biomed 19 7 (2006) 781-821
106. Lin C.C., Ding H.J., Chen Y.W., et al. Usefulness of thallium-201 muscle perfusion scan to investigate perfusion reserve in the lower limbs of Type 2 diabetic patients. J Diabetes Complications 18 4 (2004) 233-236
107. Nuutila P., and Kalliokoski K. Use of positron emission tomography in the assessment of skeletal muscle and tendon metabolism and perfusion. Scand J Med Sci Sports 10 6 (2000) 346-350
108. Goh V., Halligan S., Hugill J.A., et al. Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility. AJR Am J Roentgenol 187 1 (2006) 164-169
109. Duerschmied D., Maletzki P., Freund G., et al. Analysis of muscle microcirculation in advanced diabetes mellitus by contrast enhanced ultrasound. Diabetes Res Clin Pract 81 1 (2008) 88-92
110. Thompson R.B., Aviles R.J., Faranesh A.Z., et al. Measurement of skeletal muscle perfusion during postischemic reactive hyperemia using contrast-enhanced MRI with a step-input function. Magn Reson Med 54 2 (2005) 289-298
111. Lutz A.M., Weishaupt D., Amann-Vesti B.R., et al. Assessment of skeletal muscle perfusion by contrast medium first-pass magnetic resonance imaging: technical feasibility and preliminary experience in healthy volunteers. J Magn Reson Imaging 20 1 (2004) 111-121
112. Boss A., Martirosian P., Claussen C.D., et al. Quantitative ASL muscle perfusion imaging using a FAIR-TrueFISP technique at 3.0 T. NMR Biomed 19 1 (2006) 125-132
113. Noseworthy M.D., Bulte D.P., and Alfonsi J. BOLD magnetic resonance imaging of skeletal muscle. Semin Musculoskelet Radiol 7 4 (2003) 307-315
114. Galbraith S.M., Lodge M.A., Taylor N.J., et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 15 2 (2002) 132-142
115. Li Y., Hazarika S., Xie D., et al. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 56 3 (2007) 656-665